190 related articles for article (PubMed ID: 4605123)
1. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
2. The influence of formulation on drug action.
Münzel K
Pharm Acta Helv; 1971 Sep; 46(9):513-38. PubMed ID: 5099398
[No Abstract] [Full Text] [Related]
3. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
4. The bioavailability of digoxin.
Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
[No Abstract] [Full Text] [Related]
5. [Bioavailability of peroral antibiotic preparations].
Zak AF
Antibiotiki; 1977 Mar; 22(3):265-79. PubMed ID: 322606
[No Abstract] [Full Text] [Related]
6. [Evaluation of the physiological availability of drug substances in capsules].
Mikhaĭlova GS
Farmatsiia; 1975; 24(1):78-82. PubMed ID: 770209
[No Abstract] [Full Text] [Related]
7. Pharmaceutical sciences--1970: literature review of pharmaceutics.
Benney TL; Hamlin WE
J Pharm Sci; 1971 Jul; 60(7):959-1014. PubMed ID: 4940085
[No Abstract] [Full Text] [Related]
8. Non-equivalence of digoxin tablets.
Reissell P; Manninen V; Ojala K; Karjalainen J
Ann Clin Res; 1974; 6(0):suppl 11:4-8. PubMed ID: 4853359
[No Abstract] [Full Text] [Related]
9. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
Vogelpoel H; Welink J; Amidon GL; Junginger HE; Midha KK; Möller H; Olling M; Shah VP; Barends DM
J Pharm Sci; 2004 Aug; 93(8):1945-56. PubMed ID: 15236445
[TBL] [Abstract][Full Text] [Related]
10. [Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
Hänselmann B; Voigt R
Pharmazie; 1971 Feb; 26(2):57-77. PubMed ID: 4930108
[No Abstract] [Full Text] [Related]
11. Bioavailability and digoxin.
N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
[No Abstract] [Full Text] [Related]
12. Proceedings: Influence of formulation on absorption and clinical effect of digoxin.
Shaw TR; Howard MR; Hamer J
Br Heart J; 1974 Apr; 36(4):400. PubMed ID: 4841478
[No Abstract] [Full Text] [Related]
13. Proceedings: Penicillins: use of an animal model to predict bioavailability.
Poole JW
Rev Can Biol; 1973; 32():Suppl:43-51. PubMed ID: 4204778
[No Abstract] [Full Text] [Related]
14. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
15. [The role of biopharmaceutical parameters in drug development (author's transl)].
Thoma K
Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
[TBL] [Abstract][Full Text] [Related]
16. Pharmaceutical sciences--1973: literature review of pharmaceutics.
Herd AK; Haleblian JK
J Pharm Sci; 1974 Jul; 63(7):995-1055. PubMed ID: 4604899
[No Abstract] [Full Text] [Related]
17. Bioavailability of digoxin tablets.
Lindenbaum J
Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
[No Abstract] [Full Text] [Related]
18. Some dissolution aspects of ferrous sulfate tablets.
Blezek CE; Lach JL; Guillory JK
Am J Hosp Pharm; 1970 Jul; 27(7):533-9. PubMed ID: 5431051
[No Abstract] [Full Text] [Related]
19. Variation in the biological availability of digoxin.
Shaw TR; Howard MR; Hamer J
Lancet; 1972 Aug; 2(7772):303-7. PubMed ID: 4115034
[No Abstract] [Full Text] [Related]
20. [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].
Bodem G; Ochs H; Hahn E; Dengler HJ
Schweiz Med Wochenschr; 1977 May; 107(19):658-66. PubMed ID: 867012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
